HTG is a life science company advancing precision medicine by leveraging its innovative transcriptome-wide profiling technology to develop profiling diagnostics and novel drug candidates to determine the right therapy for the right patient.

News & Events

HTG Molecular Diagnostics Announces Certain Preliminary 2021Unaudited Financial Results

Preliminary full year 2021 unaudited revenue of $8.9 million Cash, cash equivalents and short-term marketable securities of $21.9 million as of  December 31, 2021 TUCSON, Ariz. , Jan. 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose…

Keep Reading

HTG Completes HTP Product Next-Phase Development Milestone

Expands Potential Market and Study Opportunities for HTG Transcriptome Panel TUCSON, Ariz. , Dec. 22, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology,…

Keep Reading

HTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald Radich

Renowned Physician-Scientist Brings Significant Expertise as a Pioneer in the Fields of Leukemia Research and Molecular Genetics TUCSON, Ariz. , Dec. 16, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its…

Keep Reading

Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Posters

Abstracts

Webinars

Peer Reviewed Publications

Editorials

Reviews


Careers at HTG

At HTG, we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

New Careers

Director Pharma Partnerships

Director, Scientific Collaborations

Executive Assistant to the CEO

Commercial Lab Technician

Product Manager

See All Careers


Page last updated November 09, 2021